Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency (2008)
- Authors:
- Autor USP: REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- DOI: 10.1038/nature07449
- Subjects: NEOPLASIAS; ONCOGENES; RIBOSSOMOS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
BARNA, Maria et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature, v. 456, n. 7224, p. 971-977, 2008Tradução . . Disponível em: https://doi.org/10.1038/nature07449. Acesso em: 01 out. 2024. -
APA
Barna, M., Zollo, O., Costa, M., Kondrashov, N., Rego, E., Rao, P. H., & Ruggero, D. (2008). Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature, 456( 7224), 971-977. doi:10.1038/nature07449 -
NLM
Barna M, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency [Internet]. Nature. 2008 ; 456( 7224): 971-977.[citado 2024 out. 01 ] Available from: https://doi.org/10.1038/nature07449 -
Vancouver
Barna M, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency [Internet]. Nature. 2008 ; 456( 7224): 971-977.[citado 2024 out. 01 ] Available from: https://doi.org/10.1038/nature07449 - Trangenic mice expressing hCG-NuMA-RAR'alfa' develop hematopoietic abnormalities leading to acute promyelocytic leukemia
- Role od promyelocytic leukemia (PML) protein in tumor suppression
- Estudo da relevância da inativação do CCAAT enhancer binding protein 'alfa' (C/EBP'alfa') na gênese da leucemia promielocítica
- Linfomas não Hodgkin de células T maduras e de células NK extramodais
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
- Anemia e palidez
- Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality
Informações sobre o DOI: 10.1038/nature07449 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas